The Safety and Efficacy of Tolvaptan for Patients With Tricuspid Regurgitation and Right Heart Failure After Left Heart Valves Replacement

Trial Profile

The Safety and Efficacy of Tolvaptan for Patients With Tricuspid Regurgitation and Right Heart Failure After Left Heart Valves Replacement

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Dec 2016

At a glance

  • Drugs Tolvaptan (Primary) ; Torasemide
  • Indications Tricuspid valve insufficiency
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Dec 2016 Status changed from recruiting to completed.
    • 17 Mar 2016 Status changed from active, no longer recruiting to recruiting, according to ClinicalTrials.gov record.
    • 11 Jan 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top